Bedel Financial Consulting’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15
| Closed | -$10K | – | 725 |
|
|
2022
Q1 | $10K | Hold |
15
| – | – | ﹤0.01% | 675 |
|
|
2021
Q4 | $9K | Hold |
15
| – | – | ﹤0.01% | 701 |
|
|
2021
Q3 | $9K | Hold |
15
| – | – | ﹤0.01% | 694 |
|
|
2021
Q2 | $8K | Hold |
15
| – | – | ﹤0.01% | 708 |
|
|
2021
Q1 | $7K | Hold |
15
| – | – | ﹤0.01% | 696 |
|
|
2020
Q4 | $7K | Hold |
15
| – | – | ﹤0.01% | 609 |
|
|
2020
Q3 | $8K | Sell |
15
-5
| -25% | -$2.67K | ﹤0.01% | 547 |
|
|
2020
Q2 | $12K | Hold |
20
| – | – | 0.01% | 468 |
|
|
2020
Q1 | $10K | Buy |
20
+5
| +33% | +$2.5K | 0.01% | 479 |
|
|
2019
Q4 | $6K | Sell |
15
-24
| -62% | -$9.6K | ﹤0.01% | 566 |
|
|
2019
Q3 | $11K | Hold |
39
| – | – | 0.01% | 472 |
|
|
2019
Q2 | $12K | Hold |
39
| – | – | 0.01% | 467 |
|
|
2019
Q1 | $16K | Hold |
39
| – | – | 0.01% | 418 |
|
|
2018
Q4 | $15K | Hold |
39
| – | – | 0.01% | 403 |
|
|
2018
Q3 | $15K | Hold |
39
| – | – | 0.01% | 423 |
|
|
2018
Q2 | $13K | Buy |
39
+24
| +160% | +$8K | 0.01% | 447 |
|
|
2018
Q1 | $5K | Buy |
+15
| New | +$5K | ﹤0.01% | 543 |
|